These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

361 related items for PubMed ID: 17912460

  • 1. Therapeutic immune response induced by intratumoral expression of the fusogenic membrane protein of vesicular stomatitis virus and cytokines encoded by adenoviral vectors.
    Hoffmann D, Bayer W, Wildner O.
    Int J Mol Med; 2007 Nov; 20(5):673-81. PubMed ID: 17912460
    [Abstract] [Full Text] [Related]

  • 2. Intratumoral expression of respiratory syncytial virus fusion protein in combination with cytokines encoded by adenoviral vectors as in situ tumor vaccine for colorectal cancer.
    Hoffmann D, Bayer W, Grunwald T, Wildner O.
    Mol Cancer Ther; 2007 Jul; 6(7):1942-50. PubMed ID: 17620425
    [Abstract] [Full Text] [Related]

  • 3. In situ tumor vaccination with adenovirus vectors encoding measles virus fusogenic membrane proteins and cytokines.
    Hoffmann D, Bayer W, Wildner O.
    World J Gastroenterol; 2007 Jun 14; 13(22):3063-70. PubMed ID: 17589921
    [Abstract] [Full Text] [Related]

  • 4. VSV-G pseudotyped, MuLV-based, semi-replication-competent retrovirus for cancer treatment.
    Qiao J, Moreno J, Sanchez-Perez L, Kottke T, Thompson J, Caruso M, Diaz RM, Vile R.
    Gene Ther; 2006 Oct 14; 13(20):1457-70. PubMed ID: 16724095
    [Abstract] [Full Text] [Related]

  • 5. Allogeneic tumor cells expressing fusogenic membrane glycoproteins as a platform for clinical cancer immunotherapy.
    Errington F, Bateman A, Kottke T, Thompson J, Harrington K, Merrick A, Hatfield P, Selby P, Vile R, Melcher A.
    Clin Cancer Res; 2006 Feb 15; 12(4):1333-41. PubMed ID: 16489091
    [Abstract] [Full Text] [Related]

  • 6. Adenoviral vectors expressing fusogenic membrane glycoproteins activated via matrix metalloproteinase cleavable linkers have significant antitumor potential in the gene therapy of gliomas.
    Allen C, McDonald C, Giannini C, Peng KW, Rosales G, Russell SJ, Galanis E.
    J Gene Med; 2004 Nov 15; 6(11):1216-27. PubMed ID: 15459967
    [Abstract] [Full Text] [Related]

  • 7. Immunotherapy of established tumors in mice by intratumoral injection of an adenovirus vector harboring the human IL-2 cDNA: induction of CD8(+) T-cell immunity and NK activity.
    Slos P, De Meyer M, Leroy P, Rousseau C, Acres B.
    Cancer Gene Ther; 2001 May 15; 8(5):321-32. PubMed ID: 11477452
    [Abstract] [Full Text] [Related]

  • 8. Assessment of a combined, adenovirus-mediated oncolytic and immunostimulatory tumor therapy.
    Bernt KM, Ni S, Tieu AT, Lieber A.
    Cancer Res; 2005 May 15; 65(10):4343-52. PubMed ID: 15899826
    [Abstract] [Full Text] [Related]

  • 9. In situ cancer vaccination: an IL-12 defective vector/replication-competent herpes simplex virus combination induces local and systemic antitumor activity.
    Toda M, Martuza RL, Kojima H, Rabkin SD.
    J Immunol; 1998 May 01; 160(9):4457-64. PubMed ID: 9574551
    [Abstract] [Full Text] [Related]

  • 10. Cytotoxic effect of replication-competent adenoviral vectors carrying L-plastin promoter regulated E1A and cytosine deaminase genes in cancers of the breast, ovary and colon.
    Akbulut H, Zhang L, Tang Y, Deisseroth A.
    Cancer Gene Ther; 2003 May 01; 10(5):388-95. PubMed ID: 12719708
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Combined VSV oncolytic virus and chemotherapy for squamous cell carcinoma.
    Sung CK, Choi B, Wanna G, Genden EM, Woo SL, Shin EJ.
    Laryngoscope; 2008 Feb 01; 118(2):237-42. PubMed ID: 18043494
    [Abstract] [Full Text] [Related]

  • 13. Antitumor mechanism of intratumoral injection with IL-12-expressing adenoviral vector against IL-12-unresponsive tumor.
    Kanagawa N, Gao JQ, Motomura Y, Yanagawa T, Mukai Y, Yoshioka Y, Okada N, Nakagawa S.
    Biochem Biophys Res Commun; 2008 Aug 08; 372(4):821-5. PubMed ID: 18519033
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control.
    Sorensen MR, Holst PJ, Pircher H, Christensen JP, Thomsen AR.
    Eur J Immunol; 2009 Oct 08; 39(10):2725-36. PubMed ID: 19637230
    [Abstract] [Full Text] [Related]

  • 16. Dendritic cells modified to express fractalkine/CX3CL1 in the treatment of preexisting tumors.
    Nukiwa M, Andarini S, Zaini J, Xin H, Kanehira M, Suzuki T, Fukuhara T, Mizuguchi H, Hayakawa T, Saijo Y, Nukiwa T, Kikuchi T.
    Eur J Immunol; 2006 Apr 08; 36(4):1019-27. PubMed ID: 16525992
    [Abstract] [Full Text] [Related]

  • 17. Regional treatment of hepatic micrometastasis by adenovirus vector-mediated delivery of interleukin-2 and interleukin-12 cDNAs to the hepatic parenchyma.
    Hirschowitz EA, Naama HA, Evoy D, Lieberman MD, Daly J, Crystal RG.
    Cancer Gene Ther; 1999 Apr 08; 6(6):491-8. PubMed ID: 10608345
    [Abstract] [Full Text] [Related]

  • 18. Therapeutic and specific antitumor immunity induced by co-administration of immature dendritic cells and adenoviral vector expressing biologically active IL-18.
    Tanaka F, Hashimoto W, Robbins PD, Lotze MT, Tahara H.
    Gene Ther; 2002 Nov 08; 9(21):1480-6. PubMed ID: 12378411
    [Abstract] [Full Text] [Related]

  • 19. A comparative study on the immunotherapeutic efficacy of recombinant Semliki Forest virus and adenovirus vector systems in a murine model for cervical cancer.
    Riezebos-Brilman A, Walczak M, Regts J, Rots MG, Kamps G, Dontje B, Haisma HY, Wilschut J, Daemen T.
    Gene Ther; 2007 Dec 08; 14(24):1695-704. PubMed ID: 17928874
    [Abstract] [Full Text] [Related]

  • 20. Comparative analysis of antitumor activity of CD40L, RANKL, and 4-1BBL in vivo following intratumoral administration of viral vectors or transduced dendritic cells.
    Yurkovetsky ZR, Shurin GV, Barry DA, Schuh AC, Shurin MR, Robbins PD.
    J Gene Med; 2006 Feb 08; 8(2):129-37. PubMed ID: 16288496
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.